ICU Medical (ICUI)
(Delayed Data from NSDQ)
$131.71 USD
-1.31 (-0.98%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $131.73 +0.02 (0.02%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth D Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ICUI 131.71 -1.31(-0.98%)
Will ICUI be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ICUI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ICUI
FDA Identifies ICU Medical's Plum Duo Recall as Serious Type
ICU Medical (ICUI) Surpasses Q2 Earnings and Revenue Estimates
ICUI: What are Zacks experts saying now?
Zacks Private Portfolio Services
ICU Medical (ICUI) Q1 Earnings and Revenues Beat Estimates
ICUI Stock Declines Despite Plans for Offsetting Tariff Impacts
ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps
Other News for ICUI
20 Day Moving Average Support appears for ICUI after 3.04% move
ICUI forms 20 Day Moving Average Support on September 17
The technical outlook for ICUI is unchanged after it falls 1.37% on September 16
Is ICUI likely to continue higher? 180 Bullish Setup shows up after gaining 1.37%
Is ICUI building bullish momentum? Slingshot Bullish shows up after slipping 3.44%